MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies_Pain
Pacira BioSciences, Inc. (NASDAQ:PCRX)
Organization & Developments: Pacira
Parents
Pacira BioSciences, Inc. (NASDAQ:PCRX)
Children
*Injectable, extended-release analgesic (pain) drug
2017: VA_65--Pacira Pharmaceuticals 65IB
2018: FDA advisory group rejects Pacira’s pitch for expanded use of pain drug – Endpoints News
2020: IBD Stock Of The Day Rockets To Fresh High On Rival's Unexpected Setback
2022: After buying out Flexion for $450M, Pacira quietly lays off 110 of its employees
2022: Assessing Pacira BioSciences' Growth Prospects_ seekingalpha.com
2023: Pacira BioSciences: Preparing For A Pivotal Q3 Earnings (NASDAQ:PCRX)
2023: Pacira BioSciences: Sell-Off On Pain Relief Specialist - But Recovery Not Guaranteed (NASDAQ:PCRX)
2024: Pacira BioSciences: Not Done Yet Despite Devastating Share Price Losses
2025: Pacira BioSciences: Back On An Uptrend After Positive Developments_seekingalpha.com
Jumps
*Key People: Pacira
Finance & Acquisitions: Pacira